• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种从人骨髓间充质干细胞中分离小细胞外囊泡的简易台式过滤方法。

A Simple Benchtop Filtration Method to Isolate Small Extracellular Vesicles from Human Mesenchymal Stem Cells.

机构信息

Centre for Tissue Engineering and Regenerative Medicine, Universiti Kebangsaan Malaysia Medical Centre; My CytoHealth Sdn. Bhd.

School of Biosciences, Faculty of Health and Medical Sciences, Taylor's University.

出版信息

J Vis Exp. 2022 Jun 23(184). doi: 10.3791/64106.

DOI:10.3791/64106
PMID:35816005
Abstract

The ultracentrifugation-based process is considered the common method for small extracellular vesicles (sEVs) isolation. However, the yield from this isolation method is relatively lower, and these methods are inefficient in separating sEV subtypes. This study demonstrates a simple benchtop filtration method to isolate human umbilical cord-derived MSC small extracellular vesicles (hUC-MSC-sEVs), successfully separated by ultrafiltration from the conditioned medium of hUC-MSCs. The size distribution, protein concentration, exosomal markers (CD9, CD81, TSG101), and morphology of the isolated hUC-MSC-sEVs were characterized with nanoparticle tracking analysis, BCA protein assay, western blot, and transmission electron microscope, respectively. The isolated hUC-MSC-sEVs' size was 30-200 nm, with a particle concentration of 7.75 × 10 particles/mL and a protein concentration of 80 µg/mL. Positive bands for exosomal markers CD9, CD81, and TSG101 were observed. This study showed that hUC-MSC-sEVs were successfully isolated from hUC-MSCs conditioned medium, and characterization showed that the isolated product fulfilled the criteria mentioned by Minimal Information for Studies of Extracellular Vesicles 2018 (MISEV 2018).

摘要

基于超速离心的方法被认为是分离小细胞外囊泡(sEVs)的常用方法。然而,这种分离方法的产量相对较低,并且这些方法在分离 sEV 亚型方面效率不高。本研究展示了一种简单的台式过滤方法来分离人脐带间充质干细胞来源的 MSC 小细胞外囊泡(hUC-MSC-sEVs),该方法成功地从小鼠 hUC-MSCs 的条件培养基中通过超滤分离出来。通过纳米颗粒跟踪分析、BCA 蛋白测定、western blot 和透射电子显微镜分别对分离的 hUC-MSC-sEVs 的大小分布、蛋白浓度、外泌体标志物(CD9、CD81、TSG101)和形态进行了表征。分离的 hUC-MSC-sEVs 的大小为 30-200nm,颗粒浓度为 7.75×10^9 个/mL,蛋白浓度为 80µg/mL。观察到外泌体标志物 CD9、CD81 和 TSG101 的阳性条带。本研究表明,hUC-MSC-sEVs 已成功地从小鼠 hUC-MSCs 的条件培养基中分离出来,并且表征结果表明,分离产物符合 2018 年细胞外囊泡研究最小信息(MISEV 2018)的要求。

相似文献

1
A Simple Benchtop Filtration Method to Isolate Small Extracellular Vesicles from Human Mesenchymal Stem Cells.一种从人骨髓间充质干细胞中分离小细胞外囊泡的简易台式过滤方法。
J Vis Exp. 2022 Jun 23(184). doi: 10.3791/64106.
2
Benchtop Isolation and Characterisation of Small Extracellular Vesicles from Human Mesenchymal Stem Cells.从人骨髓间充质干细胞中分离和表征小细胞外囊泡的台式方法。
Mol Biotechnol. 2021 Sep;63(9):780-791. doi: 10.1007/s12033-021-00339-2. Epub 2021 Jun 1.
3
Comparison of Curative Effect of Human Umbilical Cord-Derived Mesenchymal Stem Cells and Their Small Extracellular Vesicles in Treating Osteoarthritis.人脐带间充质干细胞及其小细胞外囊泡治疗骨关节炎的疗效比较。
Int J Nanomedicine. 2021 Dec 16;16:8185-8202. doi: 10.2147/IJN.S336062. eCollection 2021.
4
Evaluation of the Potential of Umbilical Cord Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles to Improve Rotator Cuff Healing: A Pilot Ovine Study.评估脐带间充质基质细胞衍生的小细胞外囊泡改善肩袖愈合的潜力:一项绵羊初步研究。
Am J Sports Med. 2023 Feb;51(2):331-342. doi: 10.1177/03635465221145958. Epub 2023 Jan 16.
5
MSC-Derived Small Extracellular Vesicles Attenuate Autoimmune Dacryoadenitis by Promoting M2 Macrophage Polarization and Inducing Tregs miR-100-5p.MSC 来源的小细胞外囊泡通过促进 M2 巨噬细胞极化和诱导 Tregs 来减轻自身免疫性干眼病 miR-100-5p。
Front Immunol. 2022 Jul 6;13:888949. doi: 10.3389/fimmu.2022.888949. eCollection 2022.
6
[Comparison of four methods for extracting extracellular vesicles from human umbilical cord mesenchymal stem cells].[四种从人脐带间充质干细胞中提取细胞外囊泡方法的比较]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020 Oct;36(10):897-902.
7
Small extracellular vesicles derived from umbilical cord mesenchymal stem cells repair blood-spinal cord barrier disruption after spinal cord injury through down-regulation of Endothelin-1 in rats.脐带间充质干细胞来源的小细胞外囊泡通过下调内皮素-1修复大鼠脊髓损伤后血脊髓屏障的破坏。
PeerJ. 2023 Oct 31;11:e16311. doi: 10.7717/peerj.16311. eCollection 2023.
8
Effect of Pre-Processing Storage Condition of Cell Culture-Conditioned Medium on Extracellular Vesicles Derived from Human Umbilical Cord-Derived Mesenchymal Stromal Cells.细胞培养条件培养液预处理储存条件对人脐带间充质干细胞来源的细胞外囊泡的影响。
Int J Mol Sci. 2022 Jul 13;23(14):7716. doi: 10.3390/ijms23147716.
9
Efficient preparation of high-purity and intact mesenchymal stem cell-derived extracellular vesicles.高效制备高纯度且完整的间充质干细胞衍生的细胞外囊泡。
Anal Bioanal Chem. 2024 Mar;416(8):1797-1808. doi: 10.1007/s00216-024-05193-0. Epub 2024 Feb 14.
10
A novel approach for large-scale manufacturing of small extracellular vesicles from bone marrow-derived mesenchymal stromal cells using a hollow fiber bioreactor.一种使用中空纤维生物反应器从骨髓间充质基质细胞大规模制造小细胞外囊泡的新方法。
Front Bioeng Biotechnol. 2023 Jan 24;11:1107055. doi: 10.3389/fbioe.2023.1107055. eCollection 2023.

引用本文的文献

1
Three-Dimensional Bioprinted Gelatin-Genipin Hydrogels Enriched with hUCMSC-Derived Small Extracellular Vesicles for Regenerative Wound Dressings.富含人脐带间充质干细胞衍生的小细胞外囊泡的三维生物打印明胶-京尼平水凝胶用于再生伤口敷料
Polymers (Basel). 2025 Apr 24;17(9):1163. doi: 10.3390/polym17091163.
2
Mesenchymal Stem Cell-Derived Exosomes as a Neuroregeneration Treatment for Alzheimer's Disease.间充质干细胞衍生的外泌体作为阿尔茨海默病的神经再生治疗方法
Biomedicines. 2024 Sep 17;12(9):2113. doi: 10.3390/biomedicines12092113.
3
Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic Review.
自然杀伤细胞衍生的细胞外囊泡作为癌症有前途的免疫治疗策略:系统评价。
Int J Mol Sci. 2023 Feb 16;24(4):4026. doi: 10.3390/ijms24044026.
4
Mesenchymal and Neural Stem Cell-Derived Exosomes in Treating Alzheimer's Disease.间充质干细胞和神经干细胞来源的外泌体在治疗阿尔茨海默病中的应用
Bioengineering (Basel). 2023 Feb 15;10(2):253. doi: 10.3390/bioengineering10020253.